Melita K. Kenealy

Malvern, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Immunosuppression-Associated Peripheral T-Cell Lymphoma.

Immunosuppression-Associated Peripheral T-Cell Lymphoma.

Journal: The New England journal of medicine

Published: June 15, 2026

Clinical response to azacitidine in MDS is associated with distinct DNA methylation changes in HSPCs.

Clinical response to azacitidine in MDS is associated with distinct DNA methylation changes in HSPCs.

Journal: Nature communications

Published: September 26, 2024

Favorable outcomes of DDX41-mutated myelodysplastic syndrome and low blast count acute myeloid leukemia treated with azacitidine ± lenalidomide.

Favorable outcomes of DDX41-mutated myelodysplastic syndrome and low blast count acute myeloid leukemia treated with azacitidine ± lenalidomide.

Journal: EJHaem

Published: July 28, 2023

Hemoglobin is a key determinant of quality of life before and during azacitidine-based therapy for myelodysplasia and low blast count acute myeloid leukemia.

Hemoglobin is a key determinant of quality of life before and during azacitidine-based therapy for myelodysplasia and low blast count acute myeloid leukemia.

Journal: Leukemia & lymphoma

Published: December 17, 2021

Dysregulation of immune cell and cytokine signalling correlates with clinical outcomes in myelodysplastic syndrome (MDS).

Dysregulation of immune cell and cytokine signalling correlates with clinical outcomes in myelodysplastic syndrome (MDS).

Journal: European journal of haematology

Published: September 22, 2021

A feasibility and acceptability study of an adaptation of the Mindful Self-Compassion program for adult cancer patients.

A feasibility and acceptability study of an adaptation of the Mindful Self-Compassion program for adult cancer patients.

Journal: Palliative & supportive care

Published: October 10, 2019

Phase 3 study of subcutaneous bortezomib, thalidomide, and prednisolone consolidation after subcutaneous bortezomib-based induction and autologous stem cell transplantation in patients with previously untreated multiple myeloma: the VCAT study.

Phase 3 study of subcutaneous bortezomib, thalidomide, and prednisolone consolidation after subcutaneous bortezomib-based induction and autologous stem cell transplantation in patients with previously untreated multiple myeloma: the VCAT study.

Journal: Leukemia & lymphoma

Published: February 20, 2019

Azacitidine with or without lenalidomide in higher risk myelodysplastic syndrome & low blast acute myeloid leukemia.

Azacitidine with or without lenalidomide in higher risk myelodysplastic syndrome & low blast acute myeloid leukemia.

Journal: Haematologica

Published: July 10, 2018

Results of a phase II study of thalidomide and azacitidine in patients with clinically advanced myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and low blast count acute myeloid leukemia (AML).

Results of a phase II study of thalidomide and azacitidine in patients with clinically advanced myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and low blast count acute myeloid leukemia (AML).

Journal: Leukemia & lymphoma

Published: June 09, 2016

Complete remission of Waldenström's associated generalized crystal-storing histiocytosis of IgM lambda subtype with bortezomib-based combination chemotherapy.

Complete remission of Waldenström's associated generalized crystal-storing histiocytosis of IgM lambda subtype with bortezomib-based combination chemotherapy.

Journal: Leukemia & lymphoma

Published: April 04, 2015

Treatment of chronic myelomonocytic leukemia with azacitidine.

Treatment of chronic myelomonocytic leukemia with azacitidine.

Journal: Leukemia & lymphoma

Published: September 20, 2012

When should iron chelation therapy be considered in patients with myelodysplasia and other bone marrow failure syndromes with iron overload?

When should iron chelation therapy be considered in patients with myelodysplasia and other bone marrow failure syndromes with iron overload?

Journal: Internal medicine journal

Published: April 14, 2012

Showing 1-12 of 13

Last Updated: 09/26/2026